comparemela.com

Latest Breaking News On - Sherpa healthcare partners - Page 1 : comparemela.com

Deals in brief: Accacia, Swat Mobility, and Seedflex snag funding, ComfortDelGro secures SGD 100 million, Alibaba eyes investment in fashion platform Ably, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

City ofUnited kingdomJawa tengahJakarta rayaSouth koreaSouth koreanRichard fifitaStephen rockettJagmohan gaargAsa renPhilanthropy asia allianceRoyal group indonesiaShunxi fundClub investibleClimate tech fundCentre for impact

ZWI Therapeutics, Inc Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer

/PRNewswire/ ZWI Therapeutics, Inc. (ZWI), a biotechnology company focused on the development of protein therapeutics using proprietary new polymers,.

United statesUniversity of massachusetts medical schoolLarry millerBob langerRon cohenShaoyi jiangEd mascioliRobert langerTherapeutics incMacrolide pharmaceuticalsOptio researchElixir pharmaceuticalsPrinceton universityWestchester county associationBiotechnology innovation organizationCompanies section

China Digest: Zenosic, Grit Biotechnology, Cataya bag funding

Cataya Bio has snagged $34.5 million in a Series B financing round, Zenosic has bagged $41.4 million in Series A1 financing.

Cataya bioInnoangel fundGrit biotechnologyRoads venturesEight roadsEight roads venturesSequoia capitalSincere capitalNingmeng investmentYiling capitalZhongbo capitalShunwei capitalGaorong capitalPark asset managementMatrix partners chinaSherpa healthcare partners

Grit Biotechnology Announces Closing of $60 Million Series B Financing

/PRNewswire/ On September 8, 2023, Grit Biotechnology announced the completion of a Series B financing round, raising over 60 million USD. The investment.

Jin haitaoQianhai arkLiando groupHefangtian venture partnershipQianhai ark asset management co ltdChina international capital corporation limitedAsset management association of chinaShenzhen capital groupGrit biotechnologyYuanhe capitalSherpa healthcare partnersDecheng capitalMatrix partnersTumor infiltrating lymphocyteGrit bioVice chairman

Grit Biotechnology Closes $60M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Qianhai arkLiando groupHefangtian venture partnershipGrit biotechnologyYuanhe capitalSherpa healthcare partnersDecheng capitalMatrix partnersTumor infiltrating lymphocyte

vimarsana © 2020. All Rights Reserved.